Nesvacumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Nesvacumab Usage And Synthesis

Biological Activity

Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema.

Nesvacumab(1296818-77-3)Related Product Information

• Urelumab
• varlilumab
• Eptinezumab
• Atezolizumab
• Obinutuzumab
• Sutimlimab
• Utomilumab
• Glofitamab
• Odronextamab
• Rituximab